NCT00806897View on ClinicalTrials.gov

Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®

CompletedOBSERVATIONAL

Enrollment

74

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Effectiveness data collection in connection with the use of the drug Levemir® in daily clinical practice.

Trial Locations (1)

01112

Novo Nordisk Investigational Site, Vilnius

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY